Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Says Approval From Korean Regulator

Dec 4 (Reuters) - Amplia Therapeutics Ltd  ATX.AX :
    * APPROVAL FROM KOREAN REGULATOR TO INITIATE PHASE 2 ACCENT
PANCREATIC CANCER TRIAL IN KOREA

Source text for Eikon:  ID:nASX2WtWyG 
Further company coverage:  ATX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news